In contrast, the extent of intra-model cellular phenotypic heterogeneity was not associated with ER status, mutation of the top two breast cancer driver genes (TP53 and PIK3CA) or PDTX tissue of origin (primary versus metastatic). The gene discussed is PIK3CA; the disease is breast carcinoma.